NS-018

· NS Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NS-018, covering 2022-03-09 to 2025-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis [Phase 2]